BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 1938395)

  • 1. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
    De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
    Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
    Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
    J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HMB 45 positive balloon cells in combined nevi].
    Laaff H; Kühnl-Petzoldt C
    Hautarzt; 1992 Sep; 43(9):566-8. PubMed ID: 1399602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
    Lampert A; Thomine E; Lauret P; Hemet J
    Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not diagnosable malignant melanomas].
    Neuber H; Lippold A; Hundeiker M
    Hautarzt; 1991 Apr; 42(4):220-2. PubMed ID: 1860796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
    Mérot Y; Mihm MC
    Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
    Abdou AG; Hammam MA; Farargy SE; Farag AG; El Shafey EN; Farouk S; Elnaidany NF
    Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma.
    Scolyer RA; Zhuang L; Palmer AA; Thompson JF; McCarthy SW
    Pathology; 2004 Oct; 36(5):419-27. PubMed ID: 15370111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.
    Kaddu S; Smolle J; Zenahlik P; Hofmann-Wellenhof R; Kerl H
    Melanoma Res; 2002 Jun; 12(3):271-8. PubMed ID: 12140384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi.
    Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
    Arch Dermatol; 1983 Jun; 119(6):455-62. PubMed ID: 6859885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type VII collagen antibody LH 7.2 identifies basement membrane characteristics of thin malignant melanomas.
    Kirkham N; Price ML; Gibson B; Leigh IM; Coburn P; Darley CR
    J Pathol; 1989 Mar; 157(3):243-7. PubMed ID: 2647941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nevus on nevus. Apropos of 7 case reports, 3 of them associated with other dysplasias, and 1 with an invasive malignant melanoma].
    Brufau C; Moran M; Armijo M
    Ann Dermatol Venereol; 1986; 113(5):409-18. PubMed ID: 3579111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.
    Gong J; Chen N; Zhou Q; Yang B; Wang Y; Wang X
    J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From dysplastic nevus to malignant melanoma--a study of 4 anatomoclinical cases of dysplastic nevus syndrome].
    Huynh Do P; Joris F
    Praxis (Bern 1994); 1997 Nov; 86(47):1854-9. PubMed ID: 9480503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pitfalls in the diagnosis of malignant melanoma].
    Orosz Z
    Magy Onkol; 2003; 47(1):27-39. PubMed ID: 12704452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epiluminescence image of lentiginous junctional nevi].
    Kreusch J; Rassner G
    Hautarzt; 1990 May; 41(5):274-6. PubMed ID: 2373614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.